Contact
Please use this form to send email to PR contact of this press release:
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
TO:
Please use this form to send email to PR contact of this press release:
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
TO: